Both in Pharmaceuticals
Aprea Therapeutics vs Ensysce Biosciences
Over the past year APRE returned −62.8% and ENSC returned −78.2%; their daily moves had a correlation of 0.14.
APRE −62.8% ENSC −78.2%Growth of $1, one year, split-adjusted
| Metric | APRE | ENSC |
|---|---|---|
| Price | $0.5842 | $0.5183 |
| Market cap | $7.4M | $10.1M |
| Today | −5.41% | −13.31% |
| 1 month | −22.1% | +14.5% |
| 6 months | −41.6% | +3.7% |
| Year to date | −31.5% | −43.7% |
| 1 year | −60.8% | −79.0% |
| Revenue growth (YoY) | −100.0% | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | 1,418.7× | 2.2× |
| Net cash | $41.2M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 82.1% | 137.6% |
| Short % of float | 5.7% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).